XBiotech Inc. Approves New Executive Employment Agreement for CEO John Simard, Setting $1.25 Million Base Salary and $4.53 Million Annual Bonus

XBiotech Inc. Announces New Executive Compensation Agreement for CEO John Simard XBiotech Inc. has entered into a new executive employment agreement with CEO John Simard, effective October 1, 2025. Under the new terms, Mr. Simard will maintain his annual base salary of $1,250,000 and will be eligible for an annual base bonus of $4,530,442, reflecting the average bonus paid over the past five years. Both compensation components will be adjusted for inflation at the end of each calendar year. The agreement also allows for additional stock options and cash bonuses at the discretion of the company’s Compensation Committee. If Mr. Simard retires, departs due to disability, or is terminated without cause, he or his estate will receive a severance payment equal to three years of both base salary and base bonus. Upon retirement, he will continue to serve as a consultant for at least 18 months, receiving his base salary during this period. The new agreement supersedes all previous employment arrangements between Mr. Simard and XBiotech. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. XBiotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-25-006266), on October 03, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here